Health and Healthcare
Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion
Published:
Bristol-Myers (NYSE: BMY) does not see much future in baby food. It is trying to sell its operation to a company where its is a better fit. According to the FT, that includes Pepsi (NYSE: PEP) and Kraft (NYSE: KFT). BMY wants as much as $9 billion for the business.
The reason behind the sale is that BMY wants to become a specialty drug company, driven by bio-pharmaceuticals. That works unless it doesn’t. There is some advantage to diversity.
Douglas A. McIntyre
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
